The #1 AI-powered therapy

notes – done in seconds

The #1 AI-powered therapy notes – done in seconds

This blog is brought to you by YUNG Sidekick –

the #1 AI-powered therapy notes – done in seconds

This blog is brought to you by YUNG Sidekick — the #1 AI-powered therapy notes – done in seconds

A Therapist's Guide to Diagnosing and Treating Alcohol-Induced Depression F10.14

A Therapist's Guide to Diagnosing and Treating Alcohol-Induced Depression F10.14
A Therapist's Guide to Diagnosing and Treating Alcohol-Induced Depression F10.14
A Therapist's Guide to Diagnosing and Treating Alcohol-Induced Depression F10.14

Oct 22, 2025

Mental health professionals face a complex clinical puzzle when clients present with both depression and alcohol use. Major depressive disorder affects 10% to 15% of people during their lifetime, making it the most common psychiatric disorder [3]. The relationship becomes even more intricate when we consider that people with alcohol dependence are 3.7 times more likely to also have major depressive disorder [3].

This intersection creates real diagnostic challenges for therapists. Among individuals receiving treatment for alcohol use disorder, nearly 33% met criteria for major depressive disorder in the past year, while 11% met criteria for dysthymia [3]. Alcohol abuse typically develops as a maladaptive pattern that leads to significant impairment, often resulting in tolerance, withdrawal, and compulsive drinking behaviors [8]. The stakes are high—harmful alcohol use accounts for approximately 10% of overall mortality in some countries [9].

The essential question we must answer is this: "Which came first: the persistent low mood or the regular drinking?" This determination shapes everything from accurate diagnosis to effective treatment planning. This guide examines diagnostic criteria, differential considerations, treatment approaches, and documentation practices that help you manage these complex cases with clinical confidence.

We'll explore how to identify alcohol-induced depression (F10.14), distinguish it from other conditions, and implement evidence-based interventions that address the root cause rather than just symptoms.

Understanding F10.14: What Makes Alcohol-Induced Depression Unique

Alcohol-induced depression stands apart as a distinct clinical entity. F10.14, the ICD-10 code for "alcohol abuse with alcohol-induced mood disorder," identifies cases where problematic alcohol use directly creates depressive symptoms that wouldn't exist without substance involvement [3].

ICD-10 Criteria for F10.14 Diagnosis

The World Health Organization places F10.14 under Mental, Behavioral and Neurodevelopmental disorders [7]. This diagnosis demands two clinical components occur simultaneously: harmful alcohol use patterns and clear evidence that this use directly causes mood disturbances [3].

The code encompasses:

  • Alcohol use disorder, mild, with alcohol-induced bipolar or related disorder

  • Alcohol use disorder, mild, with alcohol-induced depressive disorder [2]

Timing becomes the critical diagnostic element. Mood symptoms must develop during or within one month of significant alcohol use or withdrawal [3]. These mood changes must create clinically significant distress or functional impairment and cannot be better explained by an independent mood disorder [3].

DSM-5-TR Alignment with Substance-Induced Depression

The DSM-5-TR no longer uses "substance-induced mood disorders" as a distinct category, instead including substance-induced depressive disorder under substance/medication-induced mental disorders [3]. These conditions describe depressive symptoms occurring as a physiological consequence of substance use, whether during active use, intoxication, or withdrawal [3].

Research estimates the lifetime prevalence of substance-induced depressive disorders between 0.26% and 1% [3]. Among those with alcohol use disorder, approximately 40-60% experience substance-induced depression [3].

"Which came first: the persistent low mood or the regular drinking?" This question helps determine whether you're addressing a primary depressive disorder with comorbid alcohol use or genuine F10.14.

Typical Symptom Profile: Anhedonia, Guilt, Fatigue

Alcohol-induced depressive disorder presents as a depressive-like syndrome marked by depressed mood or anhedonia during and shortly after alcohol intoxication or withdrawal. Symptoms typically resolve after 3 to 4 weeks of abstinence [5]. This timeline provides crucial diagnostic information.

Common symptoms include:

  • Anhedonia: Reduced ability to experience pleasure from typically rewarding activities, connected to dopamine dysfunction during withdrawal [3]

  • Increased anxiety: Emerges during early abstinence and often persists, contributing significantly to relapse risk [3]

  • Guilt and dysphoria: Particularly intense following drinking episodes

  • Fatigue and sleep disturbances: Part of the negative emotional state termed "hyperkatifeia" [7]

"Let's agree on an observation period without alcohol to see the true picture of your mood." This approach serves dual purposes—both treatment intervention and diagnostic clarification to distinguish F10.14 from primary mood disorders.

Neurochemical Disruption: GABA, Glutamate, Serotonin, Dopamine

Alcohol-induced depression involves complex neurochemical changes across multiple systems:

GABA-Glutamate Imbalance: Alcohol initially enhances GABA (inhibitory) activity while suppressing glutamate (excitatory) activity. Chronic use triggers compensatory changes in the opposite direction [3]. Withdrawal creates reduced GABA-mediated inhibition and increased glutamate-mediated excitation, resulting in CNS hyperexcitability [3].

Dopamine Dysfunction: Chronic alcohol withdrawal decreases dopamine neuronal activity [3] and reduces basal dopamine levels in the striatum [3]. This hypofunctional dopamine state underlies the anhedonia and dysphoria characteristic of alcohol-induced depression [3].

Serotonin Disruption: Research establishes clear links between serotonin depletion, impulsivity, and alcohol-drinking behavior [8]. While alcohol may initially boost serotonin levels, prolonged use disrupts serotonin production, creating mood swings and depressive symptoms [9].

Stress System Activation: Addiction involves a shift from positive to negative reinforcement, where drinking becomes motivated by attempts to reduce withdrawal's emotional discomfort [7].

When drinking continues alongside severe depressive symptoms, consultation with an addiction psychiatrist becomes necessary. The neurobiological complexities often require specialized pharmacological management.

This article is for educational purposes and is not a substitute for professional medical advice. A diagnosis of F10.x should be made by a qualified specialist.

Differentiating F10.14 from Other Depressive Presentations

Accurate diagnosis requires distinguishing alcohol-induced depression from other conditions that present with similar symptoms. Clear diagnostic boundaries prevent misdiagnosis and ensure appropriate treatment selection for your clients.

F10.14 vs Major Depressive Disorder (F33)

This diagnostic decision ranks among the most challenging in behavioral healthcare. The primary distinction centers on timing. Depressive symptoms emerge specifically during active drinking periods or withdrawal and improve significantly within 2-4 weeks of abstinence [3] in F10.14 cases. Major Depressive Disorder (F33) persists regardless of drinking patterns.

Key distinguishing features:

  • Timeline: F10.14 symptoms fluctuate directly with drinking patterns, whereas F33 follows its own course independent of substance use [3]

  • Family History: F33 often includes family history of mood disorders, which is less common in pure F10.14 cases [3]

  • Response to Abstinence: F10.14 typically resolves with 3-4 weeks of abstinence, while F33 persists beyond this window [5]

"Which came first: the persistent low mood or the regular drinking?" This question helps differentiate between these conditions, though the distinction carries significant treatment implications. Misdiagnosis in either direction leads to inappropriate interventions.

F10.14 vs Alcohol Withdrawal Syndrome

Both conditions involve mood disturbances following alcohol cessation, yet they represent distinct clinical entities with different time courses and management approaches.

Alcohol withdrawal syndrome manifests primarily as autonomic hyperactivity—increased heart rate, blood pressure, tremor—alongside anxiety symptoms and potential seizures [1]. These symptoms peak within 24-72 hours after cessation and resolve within 7-10 days. Alcohol-induced depression persists longer, often for weeks, characterized more by depressed mood and anhedonia rather than autonomic features.

The neurobiological differences are significant. Withdrawal involves acute GABA-glutamate imbalance [1], while alcohol-induced depression reflects longer-term adaptations in multiple neurotransmitter systems, including serotonin and dopamine disruptions.

"Let's agree on an observation period without alcohol to see the true picture of your mood." This approach serves as both treatment and diagnostic tool, helping distinguish between withdrawal and true alcohol-induced depression.

F10.14 vs Self-Medication Hypothesis

The self-medication hypothesis suggests individuals with pre-existing mental illness use substances to alleviate painful psychiatric symptoms [10]. This creates a diagnostic dilemma: does drinking cause depression, or does depression lead to drinking?

Research supports bidirectionality in this relationship [11]. Among individuals with both conditions:

  • 9.2 million people (3.2% of the U.S. population) experience co-occurring mental illness and substance use disorders [10]

  • Approximately 50% of individuals with any mental illness suffer from substance abuse or dependence at some point [10]

The crucial diagnostic difference lies in whether mood symptoms existed before alcohol use began and whether they persist during extended abstinence periods. When primary depression drives drinking behavior, abstinence alone typically won't resolve mood symptoms fully.

AI Therapy Notes

Decision Tree for Differential Diagnosis

When clients present with both alcohol use and depressive symptoms, consider this systematic approach:

  1. Establish Timeline: Document onset of both drinking and mood symptoms

  2. Assess Severity: Evaluate alcohol use patterns and depression intensity

  3. Trial Abstinence: Observe mood changes during 3-4 weeks without alcohol

  4. Family History: Explore genetic predisposition to mood disorders

  5. Response Patterns: Note how symptoms fluctuate with drinking behavior

Complex cases often require specialized care. If drinking continues alongside severe depressive symptoms, I recommend consultation with an addiction psychiatrist, as these situations often require specialized pharmacological management.

This article is for educational purposes and is not a substitute for professional medical advice. A diagnosis of F10.x should be made by a qualified specialist.

The Role of Diagnostic Abstinence in Confirming F10.14

Accurate diagnosis of F10.14 depends primarily on a structured period of abstinence from alcohol. This diagnostic strategy offers both clarity and confirmation that depressive symptoms are indeed substance-induced rather than representing an independent mood disorder.

Using PHQ-9 and AUDIT Together

Standardized assessment tools create a more complete diagnostic picture when evaluating potential alcohol-induced depression. The Patient Health Questionnaire (PHQ-9) and Alcohol Use Disorders Identification Test (AUDIT) work as complementary measures that help establish baseline severity and track symptom changes over time.

The PHQ-9 provides several clinical advantages:

When reviewing PHQ-9 and AUDIT scores together, the temporal relationship between these measures provides essential diagnostic information. This data-driven approach helps distinguish between alcohol-induced depression and primary mood disorders.

These tools enable evidence-based treatment planning:

2–4 Week Abstinence as Diagnostic Tool

The cornerstone of F10.14 diagnosis involves a structured abstinence period from alcohol. This approach serves dual purposes: diagnostic clarification and therapeutic intervention.

Research consistently demonstrates that:

  • Up to four weeks of abstinence is required to resolve alcohol-related changes and determine whether depression is alcohol-induced [4]

  • A significant proportion of patients with alcohol-induced depression show marked improvement after just one week of abstinence [4]

  • Only 15-20% continue to have clinically significant depressive symptoms after four weeks of abstinence [4]

Evidence confirms that F10.14 diagnosis requires establishing both a pattern of harmful alcohol use and evidence that this use directly causes mood disturbances [3]. The abstinence period provides this critical evidence.

Tracking Symptom Resolution Over Time

Monitoring symptom changes during abstinence provides crucial diagnostic information. This systematic process involves:

  1. Establishing baseline depression severity using the PHQ-9

  2. Implementing a 2-4 week abstinence period

  3. Re-administering the PHQ-9 at regular intervals (typically every 2 weeks) [12]

  4. Documenting symptom changes in relation to abstinence

Temporal relationships remain the most reliable diagnostic indicator [3]. When symptoms improve significantly within 2-4 weeks of abstinence or mood disturbances fluctuate directly with drinking patterns, this strongly suggests F10.14 [3].

Regular monitoring determines whether mood disturbances resolve as expected with decreased drinking or persist in ways suggesting additional diagnoses requiring different interventions [3]. Studies show that if depressive symptoms persist beyond the 4-week mark despite abstinence, clinicians should reassess for an independent mood disorder [15].

If drinking continues alongside severe depressive symptoms, I will recommend a consultation with an addiction psychiatrist, as these cases often require specialized treatment approaches.

This article is for educational purposes and is not a substitute for professional medical advice. A diagnosis of F10.x should be made by a qualified specialist.

First-Line Treatment: Addressing Alcohol Use Before Depression

Treatment sequencing makes the difference between success and prolonged struggle. Clinical evidence consistently shows that addressing alcohol use first often resolves depressive symptoms naturally, eliminating the need for additional interventions.

Motivational Interviewing for Readiness to Change

Motivational Interviewing (MI) provides the foundation for effective alcohol-induced depression treatment. This patient-centered approach works because it meets clients where they are, rather than demanding immediate change. MI is a short-term, directive, patient-centered counseling style specifically designed to explore and resolve ambivalence about changing drinking behavior [16]. The non-judgmental guidance style helps patients move toward higher readiness to change [17].

Effective MI sessions focus on three core elements:

  • Listening empathically and evoking patients' individual reasons for changing behavior

  • Conveying accurate empathy, unconditional positive regard, and genuineness

  • Creating an atmosphere of acceptance where exploration and change can safely occur [17]

"Which came first: the persistent low mood or the regular drinking?" This question becomes particularly powerful during MI sessions, helping patients recognize patterns they may not have noticed. Research supports MI's effectiveness with depressed patients who drink. Among participants reporting hazardous drinking at baseline, MI-treated participants were significantly less likely than controls to report hazardous drinking at 3 months (60.0% vs. 81.8%) [18].

Behavioral Activation and Harm Reduction

Behavioral activation (BA) pairs exceptionally well with MI, especially when applied through a harm reduction framework. BA targets the reward dysfunction that characterizes both depression and alcohol use disorders by improving engagement with natural reinforcers [5].

The BA process helps patients rebuild meaningful activities:

  1. Identifying potentially rewarding, values-based activities that bring pleasure or accomplishment

  2. Structuring activity planning and anticipating reinforcement

  3. Problem-solving barriers to engagement in positive activities [19]

"Let's agree on an observation period without alcohol to see the true picture of your mood." I present this not just as diagnosis but as an opportunity to add structured, enjoyable activities that counter the anhedonia common during early abstinence.

Harm reduction-focused BA celebrates progress rather than perfection. One study demonstrated that participants receiving harm reduction-focused BA showed increases in behavioral activation and readiness to change drug use, alongside decreases in substance use, depression, and HIV risk behaviors [20]. This approach builds confidence while reducing alcohol use gradually.

When to Delay Antidepressant Initiation

Patience with medication decisions often serves patients better than immediate pharmaceutical intervention. Multiple studies indicate that psychotherapy alone accounts for substantial improvement in both conditions [5]. Meta-analysis of combined motivational interviewing and cognitive behavioral therapy for AUD and depression found significant improvements in both areas without medication support [5].

Consider delaying antidepressants when:

  • Depression's relationship to alcohol use remains unclear during active drinking

  • Medication side effects or alcohol interactions pose risks

  • Abstinence alone shows promise for resolving depressive symptoms

  • Research indicates some antidepressants provide no additive benefit with effective psychotherapy [5]

Most F10.14 presentations respond well to MI and BA with harm reduction principles before requiring medication interventions. However, if drinking continues alongside severe depressive symptoms, I will recommend a consultation with an addiction psychiatrist for specialized pharmacological approaches.

This article is for educational purposes and is not a substitute for professional medical advice. A diagnosis of F10.x should be made by a qualified specialist.

Therapist's Role in Documentation and Interdisciplinary Care

Effective documentation creates the foundation for successful F10.14 treatment. Your clinical notes serve multiple purposes—supporting accurate diagnosis, guiding treatment decisions, and enabling smooth collaboration with other healthcare professionals.

Sample Language for F10.14 Documentation

Clear documentation requires specific language that establishes the connection between alcohol use and mood symptoms. Your notes should capture this relationship precisely:

  • "Client reports depressive symptoms emerge during heavy alcohol use periods and improve during abstinence"

  • "Assessment indicates mood symptoms directly correlate with substance use rather than independent mood disorder"

  • "Client reports notable mood improvement after two weeks of abstinence"

Your documentation should always address the core question: "Which came first: the persistent low mood or the regular drinking?" This establishes the causal relationship essential for accurate F10.14 diagnosis.

Medical Necessity and Insurance Coding Tips

Insurance companies require specific documentation to approve F10.14 treatment. Your notes need three key elements:

Document functional impairment caused by the condition clearly. Specify how your treatment will improve client functioning. Show that symptoms require this level of care rather than less intensive services.

"Let's agree on an observation period without alcohol to see the true picture of your mood." Including therapeutic statements like this demonstrates your systematic diagnostic approach, supporting medical necessity requirements.

Accurate coding demands precision. F10.14 (alcohol abuse with alcohol-induced mood disorder) serves as your primary code, though secondary codes may be needed for complete clinical presentation. Avoid using depression-only codes when alcohol use drives the symptoms—this can create inappropriate treatment pathways.

When to Refer to Addiction Psychiatry or MAT Programs

Certain situations require specialized care beyond outpatient therapy:

  1. Severe alcohol use disorder with dangerous withdrawal risk

  2. Multiple failed abstinence attempts despite your interventions

  3. Persistent severe depression after 4 weeks of abstinence

  4. Active suicidal ideation or planning

  5. Medical complications requiring medication management

"If drinking continues alongside severe depressive symptoms, I will recommend a consultation with an addiction psychiatrist." This approach acknowledges your professional boundaries while maintaining the therapeutic relationship.

Medication-Assisted Treatment (MAT) programs benefit clients with moderate-to-severe alcohol dependence, particularly those needing pharmacological support such as naltrexone, acamprosate, or disulfiram to maintain abstinence.

Your role includes recognizing when specialized care enhances treatment outcomes rather than replacing your therapeutic work.

This article is for educational purposes and is not a substitute for professional medical advice. A diagnosis of F10.x should be made by a qualified specialist.

Risks of Misdiagnosis and Premature Depression Treatment

Misdiagnosis of alcohol-induced depression creates serious clinical consequences that extend far beyond individual treatment outcomes. Understanding these risks helps mental health professionals make better assessment and intervention decisions.

Why Antidepressants May Fail in F10.14

Premature medication interventions often fail when the underlying cause remains alcohol use rather than primary depression. Research shows approximately 16.5% of patients experience failure to respond when antidepressants are reinstated after discontinuation, with response failure rates ranging from 3.8% to 42.9% across studies [21]. This pattern occurs across all common antidepressant classes.

The biological reasons are clear. Studies reveal that serotonergic neurons of SSRI non-responders have abnormally long neurites compared to responders [6]. Alcohol directly disrupts multiple neurotransmitter systems—serotonin, dopamine, and GABA—so targeting only one pathway often proves insufficient.

"Which came first: the persistent low mood or the regular drinking?" This diagnostic question becomes crucial for avoiding premature antidepressant initiation that may obscure the true clinical picture.

Therapeutic Boundaries in Treating Severe AUD

Mental health professionals must recognize their clinical limitations when working with severe alcohol use presentations. Unsuccessful treatment and delayed proper diagnosis create predictable problems:

  • Lack of functional improvement

  • Delayed remission

  • Unnecessary or inappropriate treatments [22]

"Let's agree on an observation period without alcohol to see the true picture of your mood." This approach establishes clear therapeutic boundaries while gathering the diagnostic information needed for appropriate care.

Avoiding Time Loss in Treatment Planning

The costs of diagnostic errors compound quickly. Higher indirect costs result from greater impairment in psychosocial functioning, increased need for disability benefits, and higher workplace disability and absenteeism [23].

Missed and delayed diagnoses create cascading problems:

  • More frequent relapse and hospitalizations

  • Elevated suicide risk

  • Substantial direct and indirect economic costs [23]

"If drinking continues alongside severe depressive symptoms, I will recommend a consultation with an addiction psychiatrist." Timely referral prevents unnecessary suffering and helps avoid escalating healthcare costs.

This article is for educational purposes and is not a substitute for professional medical advice. A diagnosis of F10.x should be made by a qualified specialist.

Conclusion

Diagnosing and treating alcohol-induced depression (F10.14) requires clinical precision and patience. The foundation remains recognizing the direct relationship between alcohol use and mood symptoms. Our most valuable diagnostic tool continues to be asking: "Which came first: the persistent low mood or the regular drinking?"

The evidence supports a clear treatment sequence: address alcohol use first. This approach resolves depressive symptoms naturally in most cases, eliminating the need for additional interventions. A structured 2-4 week abstinence period provides both diagnostic clarity and therapeutic benefit.

Motivational interviewing paired with behavioral activation offers the most effective first-line approach. These interventions target the root cause while supporting your clients through the recovery process. Precise documentation that captures the temporal relationship between alcohol and mood ensures proper treatment planning and coverage approval.

Stay fully present with your clients throughout this process. Some cases will improve dramatically with abstinence alone, while others require specialized care. When severe depressive symptoms persist alongside continued drinking, consultation with an addiction psychiatry specialist becomes necessary.

Your role centers on clinical observation and therapeutic boundaries. Avoid rushing to treat depression symptoms that may resolve naturally during sobriety. The goal is helping clients understand and break the cycle where alcohol and depression fuel each other.

Successful F10.14 management depends on allowing time for the complete clinical picture to emerge. This measured approach serves your clients' best interests and supports lasting recovery.

This article is for educational purposes and is not a substitute for professional medical advice. A diagnosis of F10.x should be made by a qualified specialist.

Key Takeaways

Understanding and treating alcohol-induced depression requires a systematic approach that prioritizes accurate diagnosis through abstinence observation and addresses alcohol use before depression treatment.

Diagnostic abstinence is essential: A 2-4 week alcohol-free period serves as both diagnostic tool and treatment, with 80-85% of F10.14 cases showing significant mood improvement during this timeframe.

Address alcohol use first, not depression: Motivational interviewing and behavioral activation should precede antidepressant medication, as treating alcohol use often resolves depressive symptoms naturally.

Ask the critical diagnostic question: "Which came first: the persistent low mood or the regular drinking?" This temporal relationship distinguishes F10.14 from primary depression and guides appropriate treatment planning.

Document the causal relationship precisely: Clinical notes must establish how mood symptoms fluctuate with drinking patterns to support F10.14 diagnosis and ensure proper insurance coverage.

Recognize when to refer: If severe depressive symptoms persist alongside continued drinking after initial interventions, consultation with addiction psychiatry becomes necessary for specialized care.

The key to successful F10.14 treatment lies in clinical patience—allowing time for the true diagnostic picture to emerge during sobriety rather than rushing to treat depression symptoms that may resolve naturally with abstinence.

FAQs

What is alcohol-induced depression (F10.14)?

Alcohol-induced depression (F10.14) is a condition where problematic alcohol use directly causes depressive symptoms that wouldn't exist without substance involvement. It's characterized by depressed mood or anhedonia that occurs during and shortly after alcohol intoxication or withdrawal, typically improving after 3 to 4 weeks of abstinence.

How is alcohol-induced depression diagnosed?

Diagnosis involves establishing a clear temporal relationship between alcohol use and mood symptoms. A 2-4 week abstinence period is crucial for diagnostic clarity. Clinicians use tools like the PHQ-9 and AUDIT to track symptom changes over time. If depressive symptoms significantly improve with abstinence, it suggests F10.14.

What's the first-line treatment for alcohol-induced depression?

The primary approach is to address alcohol use before treating depression. This typically involves motivational interviewing to enhance readiness for change, combined with behavioral activation techniques. Antidepressant medication is often delayed, as many cases resolve with abstinence and psychotherapy alone.

How does alcohol-induced depression differ from major depressive disorder?

The key difference lies in the temporal relationship with alcohol use. F10.14 symptoms fluctuate directly with drinking patterns and typically improve significantly within 2-4 weeks of abstinence. Major depressive disorder, on the other hand, persists regardless of drinking patterns and often has a family history component.

When should a therapist refer a patient to specialized care for alcohol-induced depression?

Referral to an addiction psychiatrist or specialized program is recommended when severe depressive symptoms persist alongside continued drinking despite initial interventions, when there's a risk of dangerous withdrawal, or if depression doesn't improve after 4 weeks of abstinence. Suicidal ideation or medical complications also warrant immediate specialized care.

References

[1] - https://pmc.ncbi.nlm.nih.gov/articles/PMC6799954/
[2] - https://health.mil/Reference-Center/Publications/2022/02/01/Alcohol-Related-Disorders
[3] - https://pmc.ncbi.nlm.nih.gov/articles/PMC4873678/
[4] - https://www.upheal.io/icd-10-codes/alcohol-abuse-with-alcohol-induced-mood-disorder
[5] - https://www.aapc.com/codes/icd-10-codes/F10.14?srsltid=AfmBOoqcWsrCP1k_OYIZoKMj-kouey9_c2jEwM7a9mQypEStkAZh_rGf
[6] - https://www.aapc.com/codes/icd-10-codes/F10.14?srsltid=AfmBOorp-LFgtLnNsE3gjfWg7aqq_rgrTRA48_rywJowsFNFucWWsgk6
[7] - https://www.psychdb.com/mood/substance-medication
[8] - https://www.ncbi.nlm.nih.gov/books/NBK555887/
[9] - https://pmc.ncbi.nlm.nih.gov/articles/PMC6943828/
[10] - https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/neuroscience-brain-addiction-and-recovery
[11] - https://pmc.ncbi.nlm.nih.gov/articles/PMC4065474/
[12] - https://providenceproject.org/resource-hub/link-between-alcoholism-depression-brain-chemistry/
[13] - https://www.mdpi.com/1422-0067/23/23/14912
[14] - https://scholarworks.indianapolis.iu.edu/server/api/core/bitstreams/83154f06-beea-44e3-b40e-14fba940cddb/content
[15] - https://americanaddictioncenters.org/alcohol/risks-effects-dangers/depression
[16] - https://www.uspreventiveservicestaskforce.org/home/getfilebytoken/sDvjG49sFm7t3f3CnZUuFw
[17] - https://www2.gov.bc.ca/assets/gov/health/practitioner-pro/bc-guidelines/depression_patient_health_questionnaire.pdf
[18] - https://www.psychiatrist.com/jcp/alcohol-use-disorder-co-occurring-with-depressive-and-anxiety-symptoms/
[19] - https://www.camh.ca/en/professionals/treating-conditions-and-disorders/alcohol-use/alcohol-use---screening/au-screening---screening-for-alcohol-use-and-depression
[20] - https://jamanetwork.com/journals/jamapsychiatry/fullarticle/206686
[21] - https://pmc.ncbi.nlm.nih.gov/articles/PMC4919182/
[22] - https://pmc.ncbi.nlm.nih.gov/articles/PMC6121710/
[23] - https://www.jsatjournal.com/article/S0740-5472(12)00143-2/abstract
[24] - https://pmc.ncbi.nlm.nih.gov/articles/PMC12332520/
[25] - https://pubmed.ncbi.nlm.nih.gov/39179209/
[26] - https://pmc.ncbi.nlm.nih.gov/articles/PMC6191880/
[27] - https://www.medicalnewstoday.com/articles/324809
[28] - https://pmc.ncbi.nlm.nih.gov/articles/PMC11503128/
[29] - https://pmc.ncbi.nlm.nih.gov/articles/PMC10503923/

If you’re ready to spend less time on documentation and more on therapy, get started with a free trial today

Outline
Title
Title
Title

2025, Awake Technologies Inc.

66 West Flager Street, Miami, Florida, USA

2025, Awake Technologies Inc.

66 West Flager Street, Miami, Florida, USA

2025, Awake Technologies Inc.

66 West Flager Street, Miami, Florida, USA

2025, Awake Technologies Inc.

66 West Flager Street, Miami, Florida, USA

2025, Awake Technologies Inc.

66 West Flager Street, Miami, Florida, USA